London, UK, March 22, 2019 (GLOBE NEWSWIRE) -- This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017. It analyses the leading companies operating in the generic drug market and discusses forces that shape companies’ strategic directions. There have been a number of consolidation activities, mergers, acquisitions and divestitures occurring amongst the leading players in the generic drugs market over the last few years. This level of corporate activities has led to the creation of a market which is steep in growth opportunities for companies that are able to align their strategies to growth.
The lead analyst of the report commented “Related to the move towards biosimilars and the decreasing distance between originator and generic companies is the rise of the complex generics sector. As generics competition steadily increases in all markets, there are strong incentives for companies with sufficiently advanced technologies to move beyond simple generics into more complex, higher-margin products.
For free sample pages on this report please click on:
https://www.visiongain.com/report/pharma-leader-series-top-generic-drug-producers-market-forecast-2019-2029/
With differentiation likely to increase in importance as the generics market becomes more competitive, novel delivery systems and reformulations (for example, extended-release versions of original products) will also increase in significance for generics companies. Competitive strength in this field will require investment in ongoing R&D, further contributing to the closure of the gap between original and generic manufacturers.”
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 20 7549 9987
Leading companies featured in the report include Abbott, Aurobindo, EMS, Endo, Fresenius, Kabi, Mylan, Novartis (Sandoz), Pfizer, Sun Pharmaceuticals, Teva
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 20 7549 9987